Genpact (G) Stock Forecast, Price Target & Predictions
G Stock Forecast
Genpact stock forecast is as follows: an average price target of $42.25 (represents a 8.95% upside from G’s last price of $38.78) and a rating consensus of 'Hold', based on 9 wall street analysts offering a 1-year stock forecast.
G Price Target
The average price target for Genpact (G) is $42.25 based on 1-year price targets from 9 Wall Street analysts in the past 3 months, with a price target range of $46.00 to $37.00. This represents a potential 8.95% upside from G's last price of $38.78.
G Analyst Ratings
According to 9 Wall Street analysts, Genpact's rating consensus is 'Hold'. The analyst rating breakdown for G stock is 0 'Strong Buy' (0.00%), 2 'Buy' (22.22%), 7 'Hold' (77.78%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Genpact Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Oct 09, 2024 | David Koning | Robert W. Baird | $44.00 | $38.92 | 13.05% | 13.46% |
| Aug 12, 2024 | Keith Bachman | BMO Capital | $42.00 | $36.84 | 14.01% | 8.30% |
| Jun 12, 2024 | Bryan Keane | Deutsche Bank | $37.00 | $32.67 | 13.25% | -4.59% |
| May 10, 2024 | Keith Bachman | BMO Capital | $38.00 | $34.38 | 10.53% | -2.01% |
| May 11, 2023 | Keith Bachman | Loop Capital Markets | $46.00 | $36.06 | 27.57% | 18.62% |
The latest Genpact stock forecast, released on Oct 09, 2024 by David Koning from Robert W. Baird, set a price target of $44.00, which represents a 13.05% increase from the stock price at the time of the forecast ($38.92), and a 13.46% increase from G last price ($38.78).
Genpact Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | 1 | 2 | 4 |
| Avg Price Target | $44.00 | $43.00 | $40.25 |
| Last Closing Price | $38.78 | $38.78 | $38.78 |
| Upside/Downside | 13.46% | 10.88% | 3.79% |
In the current month, the average price target of Genpact stock is $44.00, according to 1 Wall Street analyst offering twelve months forecast. The average price target represents a 13.46% increase as opposed to Genpact's last price of $38.78. This month's average price target is up 2.33% compared to last quarter, and up 9.32% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Sep 09, 2024 | Jefferies | Hold | Hold | Hold |
| Aug 12, 2024 | BMO Capital | Market Perform | Market Perform | Hold |
| Aug 09, 2024 | Needham | Buy | Buy | Hold |
| Aug 09, 2024 | Cowen & Co. | Hold | Hold | Hold |
| Jul 17, 2024 | Wedbush | Market Perform | Market Perform | Hold |
| Jul 12, 2024 | Citigroup | Neutral | Neutral | Hold |
| Jun 12, 2024 | Deutsche Bank | Hold | Hold | Hold |
| May 10, 2024 | BMO Capital | Market Perform | Market Perform | Hold |
| May 10, 2024 | Cowen & Co. | Hold | Hold | Hold |
| Aug 09, 2023 | BMO Capital | Market Perform | Market Perform | Hold |
Genpact's last stock rating was published by Jefferies on Sep 09, 2024. The company gave G a "Hold" rating, the same as its previous rate.
Genpact Financial Forecast
Genpact Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $1.15B | $1.14B | $1.11B | $1.09B | $1.10B | $1.11B | $1.09B | $1.07B | $1.07B | $1.02B | $988.13M | $946.07M | $950.57M | $935.52M | $900.09M | $923.19M | $940.74M | $888.80M |
| Avg Forecast | $1.35B | $1.34B | $1.33B | $1.27B | $1.27B | $1.26B | $1.24B | $1.19B | $1.20B | $1.19B | $1.14B | $1.11B | $1.12B | $1.16B | $1.12B | $1.10B | $1.08B | $1.09B | $1.07B | $1.03B | $1.04B | $1.01B | $964.93M | $924.45M | $934.43M | $903.78M | $838.67M | $894.39M | $911.81M | $879.97M |
| High Forecast | $1.35B | $1.34B | $1.33B | $1.27B | $1.27B | $1.26B | $1.24B | $1.19B | $1.20B | $1.20B | $1.14B | $1.11B | $1.13B | $1.20B | $1.12B | $1.10B | $1.08B | $1.09B | $1.07B | $1.03B | $1.04B | $1.01B | $964.93M | $924.45M | $934.43M | $903.78M | $838.67M | $894.39M | $911.81M | $879.97M |
| Low Forecast | $1.35B | $1.34B | $1.33B | $1.27B | $1.27B | $1.26B | $1.24B | $1.19B | $1.20B | $1.18B | $1.14B | $1.11B | $1.12B | $1.14B | $1.12B | $1.10B | $1.08B | $1.09B | $1.07B | $1.03B | $1.04B | $1.01B | $964.93M | $924.45M | $934.43M | $903.78M | $838.67M | $894.39M | $911.81M | $879.97M |
| # Analysts | 3 | 3 | 4 | 5 | 4 | 5 | 2 | 2 | 3 | 7 | 3 | 3 | 6 | 8 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 4 | 5 | 4 | 5 | 9 | 9 | 9 | 13 | 13 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.02% | 0.98% | 0.99% | 0.99% | 1.02% | 1.02% | 1.01% | 1.04% | 1.03% | 1.00% | 1.02% | 1.02% | 1.02% | 1.04% | 1.07% | 1.03% | 1.03% | 1.01% |
Genpact's average Quarter revenue forecast for Mar 24 based on 3 analysts is $1.11B, with a low forecast of $1.11B, and a high forecast of $1.11B. G's average Quarter revenue forecast represents a -3.17% decrease compared to the company's last Quarter revenue of $1.15B (Dec 23).
Genpact EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 4 | 5 | 4 | 5 | 2 | 2 | 3 | 7 | 3 | 3 | 6 | 8 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 4 | 5 | 4 | 5 | 9 | 9 | 9 | 13 | 13 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $162.73M | $165.69M | $185.71M | $173.16M | $131.53M | $184.38M | $142.46M | $165.73M | $153.05M | $178.99M | $191.23M | $178.87M | $153.17M | $165.37M | $134.26M | $163.76M | $161.80M | $154.46M |
| Avg Forecast | $205.92M | $204.31M | $202.34M | $194.26M | $194.00M | $191.63M | $188.60M | $182.12M | $182.36M | $180.87M | $174.45M | $184.67M | $171.08M | $176.44M | $170.55M | $167.88M | $172.10M | $166.84M | $163.72M | $152.62M | $159.05M | $154.61M | $147.18M | $142.36M | $142.53M | $137.85M | $127.92M | $134.65M | $139.08M | $134.22M |
| High Forecast | $205.92M | $204.31M | $202.34M | $194.26M | $194.00M | $191.63M | $188.60M | $182.12M | $182.36M | $182.39M | $174.45M | $221.60M | $172.60M | $182.41M | $170.55M | $201.45M | $206.52M | $166.84M | $163.72M | $183.14M | $159.05M | $154.61M | $147.18M | $170.84M | $142.53M | $137.85M | $127.92M | $161.58M | $139.08M | $134.22M |
| Low Forecast | $205.92M | $204.31M | $202.34M | $194.26M | $194.00M | $191.63M | $188.60M | $182.12M | $182.36M | $179.35M | $174.45M | $147.73M | $171.08M | $173.97M | $170.55M | $134.30M | $137.68M | $166.84M | $163.72M | $122.09M | $159.05M | $154.61M | $147.18M | $113.89M | $142.53M | $137.85M | $127.92M | $107.72M | $139.08M | $134.22M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.95% | 0.94% | 1.09% | 1.03% | 0.76% | 1.11% | 0.87% | 1.09% | 0.96% | 1.16% | 1.30% | 1.26% | 1.07% | 1.20% | 1.05% | 1.22% | 1.16% | 1.15% |
3 analysts predict G's average Quarter EBITDA for Mar 24 to be $184.67M, with a high of $221.60M and a low of $147.73M. This is 13.48% upper than Genpact's previous annual EBITDA (Dec 23) of $162.73M.
Genpact Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 4 | 5 | 4 | 5 | 2 | 2 | 3 | 7 | 3 | 3 | 6 | 8 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 4 | 5 | 4 | 5 | 9 | 9 | 9 | 13 | 13 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $291.31M | $117.59M | $116.25M | $106.10M | $89.71M | $95.84M | $71.67M | $96.18M | $73.08M | $102.39M | $102.70M | $91.27M | $74.98M | $85.44M | $62.16M | $85.70M | $82.20M | $88.12M |
| Avg Forecast | $182.72M | $179.10M | $172.77M | $139.30M | $163.50M | $157.85M | $153.10M | $134.10M | $151.40M | $145.41M | $130.61M | $101.01M | $133.24M | $134.67M | $124.27M | $91.82M | $82.18M | $127.41M | $117.01M | $83.48M | $94.39M | $101.92M | $97.59M | $72.65M | $88.78M | $89.02M | $62.22M | $70.46M | $100.66M | $94.17M |
| High Forecast | $182.72M | $179.10M | $172.77M | $139.30M | $163.50M | $157.85M | $153.10M | $134.10M | $151.40M | $147.22M | $130.61M | $121.21M | $144.04M | $138.31M | $124.27M | $110.19M | $98.62M | $127.41M | $117.01M | $100.17M | $94.39M | $101.92M | $97.59M | $87.18M | $88.78M | $89.02M | $62.22M | $84.56M | $100.66M | $94.17M |
| Low Forecast | $182.72M | $179.10M | $172.77M | $139.30M | $163.50M | $157.85M | $153.10M | $134.10M | $151.40M | $143.59M | $130.61M | $80.80M | $129.64M | $131.03M | $124.27M | $73.46M | $65.74M | $127.41M | $117.01M | $66.78M | $94.39M | $101.92M | $97.59M | $58.12M | $88.78M | $89.02M | $62.22M | $56.37M | $100.66M | $94.17M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 2.19% | 0.87% | 0.94% | 1.16% | 1.09% | 0.75% | 0.61% | 1.15% | 0.77% | 1.00% | 1.05% | 1.26% | 0.84% | 0.96% | 1.00% | 1.22% | 0.82% | 0.94% |
Genpact's average Quarter net income forecast for Mar 24 is $101.01M, with a range of $80.80M to $121.21M. G's average Quarter net income forecast represents a -65.33% decrease compared to the company's last Quarter net income of $291.31M (Dec 23).
Genpact SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 4 | 5 | 4 | 5 | 2 | 2 | 3 | 7 | 3 | 3 | 6 | 8 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 4 | 5 | 4 | 5 | 9 | 9 | 9 | 13 | 13 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $237.42M | $229.73M | $229.43M | $216.49M | $236.56M | $231.44M | $233.10M | $237.30M | $244.86M | $215.96M | $204.17M | $200.73M | $207.86M | $198.34M | $183.27M | $194.38M | $210.05M | $192.00M |
| Avg Forecast | $289.61M | $287.35M | $284.57M | $273.21M | $272.84M | $269.51M | $265.24M | $256.13M | $256.47M | $254.38M | $245.34M | $249.21M | $240.60M | $248.15M | $239.86M | $226.55M | $275.33M | $234.65M | $230.26M | $205.96M | $223.69M | $217.44M | $206.99M | $159.77M | $200.45M | $193.88M | $179.91M | $159.82M | $195.60M | $188.77M |
| High Forecast | $289.61M | $287.35M | $284.57M | $273.21M | $272.84M | $269.51M | $265.24M | $256.13M | $256.47M | $256.51M | $245.34M | $299.05M | $242.75M | $256.54M | $239.86M | $271.86M | $330.40M | $234.65M | $230.26M | $247.15M | $223.69M | $217.44M | $206.99M | $191.72M | $200.45M | $193.88M | $179.91M | $191.78M | $195.60M | $188.77M |
| Low Forecast | $289.61M | $287.35M | $284.57M | $273.21M | $272.84M | $269.51M | $265.24M | $256.13M | $256.47M | $252.24M | $245.34M | $199.36M | $240.60M | $244.67M | $239.86M | $181.24M | $220.26M | $234.65M | $230.26M | $164.76M | $223.69M | $217.44M | $206.99M | $127.81M | $200.45M | $193.88M | $179.91M | $127.86M | $195.60M | $188.77M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.99% | 0.93% | 0.96% | 0.96% | 0.86% | 0.99% | 1.01% | 1.15% | 1.09% | 0.99% | 0.99% | 1.26% | 1.04% | 1.02% | 1.02% | 1.22% | 1.07% | 1.02% |
Genpact's average Quarter SG&A projection for Mar 24 is $249.21M, based on 3 Wall Street analysts, with a range of $199.36M to $299.05M. The forecast indicates a 4.96% rise compared to G last annual SG&A of $237.42M (Dec 23).
Genpact EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 4 | 5 | 4 | 5 | 2 | 2 | 3 | 7 | 3 | 3 | 6 | 8 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 4 | 5 | 4 | 5 | 9 | 9 | 9 | 13 | 13 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | $1.59 | $0.65 | $0.63 | $0.58 | $0.49 | $0.52 | $0.39 | $0.52 | $0.39 | $0.55 | $0.55 | $0.48 | $0.40 | $0.45 | $0.33 | $0.45 | $0.43 | $0.46 |
| Avg Forecast | $1.01 | $0.99 | $0.95 | $0.77 | $0.90 | $0.87 | $0.85 | $0.74 | $0.84 | $0.80 | $0.72 | $0.68 | $0.74 | $0.74 | $0.69 | $0.65 | $0.68 | $0.70 | $0.65 | $0.53 | $0.52 | $0.56 | $0.54 | $0.48 | $0.49 | $0.49 | $0.34 | $0.45 | $0.56 | $0.52 |
| High Forecast | $1.01 | $0.99 | $0.95 | $0.77 | $0.90 | $0.87 | $0.85 | $0.74 | $0.84 | $0.81 | $0.72 | $0.68 | $0.80 | $0.76 | $0.69 | $0.65 | $0.68 | $0.70 | $0.65 | $0.53 | $0.52 | $0.56 | $0.54 | $0.48 | $0.49 | $0.49 | $0.34 | $0.45 | $0.56 | $0.52 |
| Low Forecast | $1.01 | $0.99 | $0.95 | $0.77 | $0.90 | $0.87 | $0.85 | $0.74 | $0.84 | $0.79 | $0.72 | $0.68 | $0.72 | $0.72 | $0.69 | $0.65 | $0.68 | $0.70 | $0.65 | $0.53 | $0.52 | $0.56 | $0.54 | $0.48 | $0.49 | $0.49 | $0.34 | $0.45 | $0.56 | $0.52 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 2.16% | 0.87% | 0.92% | 0.89% | 0.72% | 0.74% | 0.60% | 0.99% | 0.75% | 0.98% | 1.02% | 0.99% | 0.82% | 0.91% | 0.96% | 1.00% | 0.77% | 0.88% |
According to 3 Wall Street analysts, Genpact's projected average Quarter EPS for Mar 24 is $0.68, with a low estimate of $0.68 and a high estimate of $0.68. This represents a -57.16% decrease compared to G previous annual EPS of $1.59 (Dec 23).
Genpact Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| TTEC | TTEC | $4.99 | $35.67 | 614.83% | Hold |
| TWKS | Thoughtworks | $4.46 | $13.63 | 205.61% | Hold |
| CLVT | Clarivate | $6.45 | $14.33 | 122.17% | Buy |
| WNS | WNS | $47.72 | $72.86 | 52.68% | Buy |
| CDW | CDW | $191.10 | $232.80 | 21.82% | Buy |
| G | Genpact | $38.78 | $42.25 | 8.95% | Hold |
| ASGN | ASGN | $91.43 | $99.00 | 8.28% | Hold |
| PRFT | Perficient | $75.96 | $81.00 | 6.64% | Hold |
| JKHY | Jack Henry & Associates | $184.32 | $191.80 | 4.06% | Buy |
| CACI | CACI | $553.27 | $491.11 | -11.24% | Buy |
| SAIC | Science Applications | $146.14 | $124.30 | -14.94% | Buy |
| BR | Broadridge Financial Solutions | $209.64 | $176.00 | -16.05% | Buy |
| EXLS | ExlService | $42.12 | $32.64 | -22.51% | Buy |
G Forecast FAQ
Is Genpact a good buy?
No, according to 9 Wall Street analysts, Genpact (G) is considered a 'Hold'. The rating consensus is based on 0 'Strong Buy' and 2 'Buy' recommendations, accounting for 22.22% of G's total ratings.
What is G's price target?
Genpact (G) average price target is $42.25 with a range of $37 to $46, implying a 8.95% from its last price of $38.78. The data is based on 9 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Genpact stock go up soon?
According to Wall Street analysts' prediction for G stock, the company can go up by 8.95% (from the last price of $38.78 to the average price target of $42.25), up by 18.62% based on the highest stock price target, and down by -4.59% based on the lowest stock price target.
Can Genpact stock reach $60?
G's average twelve months analyst stock price target of $42.25 does not support the claim that Genpact can reach $60 in the near future.
What is Genpact's current price target trend?
1 Wall Street analyst forecast a $44 price target for Genpact (G) this month, up 13.46% from its last price of $38.78. Compared to the last 3 and 12 months, the average price target increased by 10.88% and increased by 3.79%, respectively.
What are Genpact's analysts' financial forecasts?
Genpact's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $4.96B (high $4.96B, low $4.96B), average EBITDA is $756.34M (high $756.34M, low $756.34M), average net income is $608.54M (high $608.54M, low $608.54M), average SG&A $1.06B (high $1.06B, low $1.06B), and average EPS is $3.36 (high $3.36, low $3.36). G's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $5.29B (high $5.29B, low $5.29B), average EBITDA is $806.83M (high $806.83M, low $806.83M), average net income is $673.9M (high $673.9M, low $673.9M), average SG&A $1.13B (high $1.13B, low $1.13B), and average EPS is $3.73 (high $3.73, low $3.73).
Did the G's actual financial results beat the analysts' financial forecasts?
Based on Genpact's last annual report (Dec 2023), the company's revenue was $4.48B, which missed the average analysts forecast of $4.5B by -0.43%. Apple's EBITDA was $630.86M, missing the average prediction of $685.94M by -8.03%. The company's net income was $631.26M, beating the average estimation of $484.01M by 30.42%. Apple's SG&A was $913.06M, missing the average forecast of $955.17M by -4.41%. Lastly, the company's EPS was $3.41, beating the average prediction of $2.82 by 21.07%. In terms of the last quarterly report (Dec 2023), Genpact's revenue was $1.15B, beating the average analysts' forecast of $1.12B by 2.20%. The company's EBITDA was $162.73M, missing the average prediction of $171.08M by -4.88%. Genpact's net income was $291.31M, beating the average estimation of $133.24M by 118.64%. The company's SG&A was $237.42M, missing the average forecast of $240.6M by -1.32%. Lastly, the company's EPS was $1.59, beating the average prediction of $0.736 by 115.89%